Search Results for: HCV

February 23, 2015February 23, 2015

Hepatitis C Video by Canadian Gastrointestinal Society to Foster Infection Awareness

Hepatitis C, News

In Canada, hepatitis C affects at least 350,000 individuals — some of whom are not even aware of their infection and continue transmitting the virus. To call attention to this ... Read more

February 13, 2015February 13, 2015

Study Reveals Hepatitis C Lacks Equal Attention Than HIV/AIDS or Ebola Yet is More Prevalent

Hepatitis B, Hepatitis C, News

A new study on Hepatitis C virus in West Africa entitled “High Frequency of Active HCV Infection Among Seropositive Cases in West Africa and Evidence for Multiple Transmission Pathways” was ... Read more

February 11, 2015February 13, 2015

AbbVie Reports Phase 3 Data on Ombitasvir-Paritaprevir-Ritonavir Therapy for Hepatitis C in Japan

Hepatitis C, News

AbbVie announced findings from a Phase 3 clinical trial (GIFT-I (M13-004)) for its new oral, ribavirin (RBV)-free antiviral treatment with a fixed-dose combination of paritaprevir/ritonavir (150/100 mg) with ombitasvir (25 mg), ... Read more

January 28, 2015January 28, 2015

Hepatitis C Treatment VIEKIRAX® + EXVIERA® Now EMA-Approved

News

The European Commission has granted marketing authorizations for AbbVie’s all-oral, interferon-free, short-course treatment with VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets). This treatment was recently approved with or without ribavirin (RBV) for patients suffering ... Read more

January 14, 2015January 14, 2015

Hepatitis C Patients Protest Limited Access to Sofosbuvir

News

Hundreds of hepatitis C patients and respective supporters protested in Madrid last December, complaining about the cuts in public spending that have significantly reduced public access to Sovaldi (sofosbuvir), a ... Read more

January 9, 2015January 9, 2015

Hepatitis C Treatment Response Affected by Genetic Interferon Activity

Hepatitis A, News

While hepatitis A has a wide range of available treatment options, not all patients are cured of the disease. A recent study from the Aarhus University in Denmark attempted to understand this ... Read more

January 5, 2015January 5, 2015

PCORI Board Grants $50 Million Funding for Hepatitis C Clinical Effectiveness Research

Hepatitis C, News

The Patient-Centered Outcomes Research Institute (PCORI) has granted $50 million for the development of four comparative clinical effectiveness research (CER) studies dedicated to the diagnosis and treatment of hepatitis C virus (HCV) ... Read more

December 22, 2014December 22, 2014

Viekira Pak™ From AbbVie Approved By FDA For Chronic Genotype 1 (GT1) Hepatitis C

Hepatitis C, News

Viekira Pak™ from AbbVie recently received FDA approval for the treatment of people suffering with chronic genotype 1 (GT1) hepatitis C. The recently approved Viekira, with or without ribavirin (RBV), is an oral interferon-free treatment for patients ... Read more

December 15, 2014December 15, 2014

Study Reveals Hepatitis C Does Not Cause Mental Impairment in HIV

Hepatitis C, News

A new study published in the journal Neurology entitled “Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people” examined the effect of hepatitis C virus (HCV) on neurocognitive ... Read more

December 11, 2014December 20, 2014

Simeprevir as Effective as Standard Hepatitis C Therapy with Telaprevir

Hepatitis C, News

Treating patients who suffer from chronic Hepatitis C virus infection (HCV) with once a day protease inhibitor simeprevir along with interferon and ribavirin has been demonstrated to be as effective as administering them with telaprevir with ... Read more